β-Lactoglobulin-naringenin complexes: Nano-vehicles for the delivery of a hydrophobic nutraceutical

Food Hydrocolloids

Volumn 40, Issue , 2014, Pages 214-224

  Shpigelman, Avi ^a   Shoham, Yanai ^a   Israeli Lev, Gal ^a   Livney, Yoav D ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Crystallization; Naringenin; Naringin; Nutraceutical delivery; Protein polyphenol interactions; Lactoglobulin ( Lg)

Indexed keywords

BEVERAGES; BINDING SITES; FLAVONOIDS; HYDROPHOBICITY; LIGHT SCATTERING; SOLUBILITY;

GLYCOSYLATED; HYDROPHOBICS; LACTOGLOBULIN; NARINGENIN; NARINGIN; NUTRACEUTICAL DELIVERY; NUTRACEUTICALS; POLYPHENOLS; PROTEIN-POLYPHENOL INTERACTIONS; Β-LACTOGLOBULIN;

PROTEINS;

EID: 84897469405     PISSN: 0268005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodhyd.2014.02.023     Document Type: Article

References (59)

1. Anslyn E.V., Dougherty D.A. Solutions and non-covalent binding forces. Modern physical organic chemistry 2005, 145-175. University Science Books, Sausalito, California.
2. Belitz H.D., Grosch W., Schieberle P. Enzymes. Food chemistry 2009, Springer, Berlin. 4 ed.
3. Brownlow S., Cabral J.H.M., Cooper R., Flower D.R., Yewdall S.J., Polikarpov I., et al. Bovine beta-lactoglobulin at 1.8 A resolution- still an enigmatic lipocalin. Structure 1997, 5(4):481-495.
4. Cavia-Saiz M., Muniz P., Ortega N., Busto M.D. Effect of enzymatic debittering on antioxidant capacity and protective role against oxidative stress of grapefruit juice in comparison with adsorption on exchange resin. Food Chemistry 2011, 125(1):158-163.
5. Chaneton L., Perez Saez J.M., Bussmann L.E. Antimicrobial activity of bovine beta-lactoglobulin against mastitis-causing bacteria. Journal of Dairy Science 2011, 94(1):138-145.
6. Edwards P.J.B., Jameson G.B., Palmano K.P., Creamer L.K. Heat-resistant structural features of bovine beta-lactoglobulin A revealed by NMR H/D exchange observations. International Dairy Journal 2002, 12(4):331-344.
7. Erlund I. Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutrition Research 2004, 24(10):851-874.
8. Felgines C., Texier O., Morand C., Manach C., Scalbert A., Régerat F., et al. Bioavailability of the flavanone naringenin and its glycosides in rats. American Journal of Physiology - Gastrointestinal and Liver Physiology 2000, 279(6):G1148-G1154.
9. Gao K., Henning S.M., Niu Y., Youssefian A.A., Seeram N.P., Xu A., et al. The citrus flavonoid naringenin stimulates DNA repair in prostate cancer cells. The Journal of Nutritional Biochemistry 2006, 17(2):89-95.
10. Goldwasser J., Cohen P.Y., Lin W., Kitsberg D., Balaguer P., Polyak S.J., et al. Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. Journal of Hepatology 2011, 55(5):963-971.
11. Heo H.J., Kim D.-O., Shin S.C., Kim M.J., Kim B.G., Shin D.-H. Effect of antioxidant flavanone, naringenin, from citrus junos on neuroprotection. Journal of Agricultural and Food Chemistry 2004, 52(6):1520-1525.
12. Hirose K. Quantitative analysis of binding properties. Analytical methods in supramolecular chemistry 2012, Vol. 1:29-32. Wiley-VCH, Weinheim. 2nd ed.
13. Horter D., Dressman J.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Advanced Drug Delivery Reviews 1997, 25(1):3-14.
14. Hu Y.-J., Wang Y., Ou-Yang Y., Zhou J., Liu Y. Characterize the interaction between naringenin and bovine serum albumin using spectroscopic approach. Journal of Luminescence 2010, 130:1394-1399.
15. Huang L.-F., Tong W.-Q. Impact of solid state properties on developability assessment of drug candidates. Advanced Drug Delivery Reviews 2004, 56(3):321-334.
16. Jeong K.-W., Lee J.-Y., Kang D.-I., Lee J.-U., Shin S.Y., Kim Y. Screening of flavonoids as candidate antibiotics against Enterococcus faecalis. Journal of Natural Products 2009, 72(4):719-724.
17. Jung U.J., Kim H.J., Lee J.S., Lee M.K., Kim H.O., Park E.J., et al. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clinical Nutrition 2003, 22(6):561-568.
18. Kontopidis G., Holt C., Sawyer L. Invited review: beta-lactoglobulin: binding properties, structure, and function. Journal of Dairy Science 2004, 87(4):785-796.
19. Kumpulainen J.T., Lehtonen M., Mattila P. Trolox equivalent antioxidant capacity of average flavonoid intake in Finland. Natural antioxidants in nutrition, health and disease 1999, 141-150. The Royal Society of Chemistry, Cambridge. J.T. Kumpulainen, J.T. Salonen (Eds.).
20. Kurowska E.M., Borradaile N.M., Spence J.D., Carroll K.K. Hypocholesterolemic effects of dietary citrus juices in rabbits. Nutrition Research 2000, 20(1):121-129.
21. Ladaniya M. Citrus fruit: Biology, technology and evaluation 2008, Academic, London.
22. Lakowicz J. Principles of fluorescence spectroscopy 2006, Springer, New York. 3 ed.
23. Lee K.-A., Moon S., Kim K.-T., Mendonca A., Paik H.-D. Antimicrobial effects of various flavonoids on Escherichia coli O157:H7 cell growth and lipopolysaccharide production. Food Science and Biotechnology 2010, 19(1):257-261.
24. Le Marchand L., Murphy S.P., Hankin J.H., Wilkens L.R., Kolonel L.N. Intake of flavonoids and lung cancer. Journal of the National Cancer Institute 2000, 92(2):154-160.
25. Liang L., Tajmir-Riahi H.A., Subirade M. Interaction of beta-Lactoglobulin with resveratrol and its biological implications. Biomacromolecules 2008, 9(1):50-56.
26. Livney Y.D. Milk proteins as vehicles for bioactives. Current Opinion in Colloid & Interface Science 2010, 15(1-2):73-83.
27. Loch J.I., Polit A., Bonarek P., Olszewska D., Kurpiewska K., Dziedzicka-Wasylewska M., et al. Structural and thermodynamic studies of binding saturated fatty acids to bovine beta-lactoglobulin. International Journal of Biological Macromolecules 2012, 50(4):1095-1102.
28. Löf D., Schillén K., Nilsson L. Flavonoids: precipitation kinetics and interaction with surfactant micelles. Journal of Food Science 2011, 76(3):N35-N39.
29. Mielczarek C. Acid-base properties of selected flavonoid glycosides. European Journal of Pharmaceutical Sciences 2005, 25:273-279.
30. Muller R.H., Shegokar R., Gohla S., Keck C.M. Nanocrystals: production, cellular drug delivery, current and future products. Intracellular delivery: Fundamentals and applications 2011, Vol. 5:411-432. Springer, New York.
31. Mulvihill E.E., Assini J.M., Sutherland B.G., DiMattia A.S., Khami M., Koppes J.B., et al. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat fed low-density lipoprotein receptor null mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2010, 30(4):742-748.
32. Nijveldt R.J., van Nood E., van Hoorn D.E.C., Boelens P.G., van Norren K., van Leeuwen P.A.M. Flavonoids: a review of probable mechanisms of action and potential applications. The American Journal of Clinical Nutrition 2001, 74(4):418-425.
33. Paredes A., Alzuru M., Mendez J., Rodríguez-Ortega M. Anti-sindbis activity of flavanones hesperetin and naringenin. Biological and Pharmaceutical Bulletin 2003, 26(1):108-109.
34. Rawel H.M., Frey S.K., Meidtner K., Kroll J., Schweigert F.J. Determining the binding affinities of phenolic compounds to proteins by quenching of the intrinsic tryptophan fluorescence. Molecular Nutrition & Food Research 2006, 50(8):705-713.
35. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine 1996, 20(7):933-956.
36. Riihimaki L.H., Vainio M.J., Heikura J.M.S., Valkonen K.H., Virtanen V.T., Vuorela P.M. Binding of phenolic compounds and their derivatives to bovine and Reindeer beta-lactoglobulin. Journal of Agricultural and Food Chemistry 2008, 56:7721-7729.
37. Ross J.B.A., Laws W.R., Shea M.A. Intrinsic fluorescence in protein structure analysis. Methods in protein structure and stability analysis: Luminescence spectroscopy and circular dichroism 2007, 55-70. Nova Science Publishers, New York. V.N. Uversky, E.A. Permyakov (Eds.).
38. Rouseff R.L., Martin S.F., Youtsey C.O. Quantitative survey of narirutin, naringin, hesperidin, and neohesperidin in citrus. Journal of Agricultural and Food Chemistry 1987, 35(6):1027-1030.
39. Sahu A., Kasoju N., Bora U. Fluorescence study of the curcumin - casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules 2008, 9(10):2905-2912.
40. Sawyer L., Brownlow S., Polikarpov I., Wu S.Y. β-Lactoglobulin: structural studies, biological clues. International Dairy Journal 1998, 8(2):65-72.
41. Sawyer L., Kontopidis G. The core lipocalin, bovine beta-lactoglobulin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 2000, 1482(1-2):136-148.
42. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. The Journal of Nutrition 2000, 130(8):2073S-2085S.
43. SciFinder Naringenin (CAS registry number 480-41-1) aqueous solubility calculated using ACD/Labs software 2012, Chemical Abstracts Service.
44. Semalty A., Semalty M., Singh D., Rawat M. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2010, 67(3):253-260.
45. Shpigelman A., Israeli G., Livney Y.D. Thermally-induced protein-polyphenol co-assemblies: beta lactoglobulin-based nanocomplexes as protective nanovehicles for EGCG. Food Hydrocolloids 2010, 24(8):735-743.
46. Shulman M., Cohen M., Soto-Gutierrez A., Yagi H., Wang H., Goldwasser J., et al. Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin. Plos One 2011, 6(4):e18033.
47. So V.F., Guthrie N., Chambers A.F., Moussa M., Carroll K.K. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutrition and Cancer 1996, 26(2):167-181.
48. Stǎnciuc N., Aprodu I., Râpeanu G., Bahrim G. Fluorescence spectroscopy and molecular modeling investigations on the thermally induced structural changes of bovine β-lactoglobulin. Innovative Food Science & Emerging Technologies 2012, 15(0):50-56.
49. Taheri-Kafrani A., Bordbar A.-K., Mousavi S.H.-A., Haertle T. β-Lactoglobulin structure and retinol binding changes in presence of anionic and neutral detergents. Journal of Agricultural and Food Chemistry 2008, 56(16):7528-7534.
50. Wilcox L.J., Borradaile N.M., Huff M.W. Antiatherogenic properties of naringenin, a citrus flavonoid. Cardiovascular Drug Reviews 1999, 17(2):160-178.
51. Xiao J., Chen T., Cao H., Chen L., Yang F. Molecular property-affinity relationship of flavanoids and flavonoids for HSA invitro. Molecular Nutrition & Food Research 2011, 55:310-317.
52. Xiao J., Mao F., Yang F., Zhao Y., Zhang C., Yamamoto K. Interaction of dietary polyphenols with bovine milk proteins: molecular structure-affinity relationship and influencing bioactivity aspects. Molecular Nutrition & Food Research 2011, 55:1637-1645.
53. Yang M.C., Chen N.C., Chen C.-J., Wu C.Y., Mao S.J.T. Evidence for beta-lactoglobulin involvement in vitamin D transport invivo-role of the gamma-turn (Leu-Pro-Met) of beta-lactoglobulin in vitamin D binding. Febs Journal 2009, 276(8):2251-2265.
54. Yao L.H., Jiang Y.M., Shi J., TomÁS-BarberÁN F.A., Datta N., Singanusong R., et al. Flavonoids in food and their health benefits. Plant Foods for Human Nutrition (Formerly Qualitas Plantarum) 2004, 59(3):113-122.
55. Yen F.L., Wu T.H., Lin L.T., Cham T.M., Lin C.C. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Pharmaceutical Research 2009, 26(4):893-902.
56. Zadow J.G. Utilization of milk components: whey. Modern dairy technology, advances in milk processing 1994, Vol. 1:313-373. Chapman & Hall, London. 2nd ed.
57. Zamora-Ros R., Andres-Lacueva C., Lamuela-Raventos R.M., Berenguer T., Jakszyn P., Barricarte A., et al. Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). Journal of the American Dietetic Association 2010, 110(3):390-398.
58. Zhang Y., Li Y., Dong L., Li J., He W., Chen X., et al. Investigation of the interaction between naringin and human serum albumin. Journal of Molecular Structure 2008, 875:1-8.
59. Zimet P., Livney Y.D. Beta-lactoglobulin and its nanocomplexes with pectin as vehicles for omega-3 polyunsaturated fatty acids. Food Hydrocolloids 2009, 23(4):1120-1126.